Point72 Asset Management
ZURA icon

Point72 Asset Management’s Zura Bio ZURA Stock Holding History

Point72 Asset Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-872,662
Closed -$5.19M – 4668
2026
Q1 		$5.19M Buy
872,662
+645,829
+285% +$3.9M 0.01% 1684
2025
Q4 		$1.19M Sell
226,833
-499,495
-69% -$1.98M ﹤0.01% 2775
2025
Q3 		$3.15M Sell
726,328
-1,623,672
-69% -$2.92M 0.01% 1252
2025
Q2 		$2.47M Hold
2,350,000
– – ﹤0.01% 1215
2025
Q1 		$3.03M Sell
2,350,000
-63,127
-3% -$99.6K 0.01% 1115
2024
Q4 		$6.03M Hold
2,413,127
– – 0.01% 887
2024
Q3 		$9.8M Hold
2,413,127
– – 0.02% 650
2024
Q2 		$8.45M Buy
+2,413,127
New +$9.84M 0.02% 668
2023
Q4 		– Sell
-21,100
Closed -$139K – 2948
2023
Q3 		$139K Sell
21,100
-448,177
-96% -$3M ﹤0.01% 1873
2023
Q2 		$3.85M Buy
+469,277
New +$3.77M 0.01% 893

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Point72 Asset Management's ZURA Position: Q2 2026 in Review

Point72 Asset Management sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 872,662 shares — an estimated $5.19M sold.

Point72 Asset Management first reported a position in ZURA in Q2 2023 and held it in 10 quarters. The position peaked at $9.8M in Q3 2024. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Point72 Asset Management reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 872,662 Zura Bio shares in Q2 2026, an estimated $5.19M.
  • Point72 Asset Management first reported a position in Zura Bio in Q2 2023 and held it in 10 quarters.
  • Point72 Asset Management's Zura Bio position peaked at $9.8M in Q3 2024.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.